Sofinnova Venture Partners X L.P. 13D and 13G filings for Y-mAbs Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 6:45 pm Purchase | 2021-11-04 | 13D | Y-mAbs Therapeutics, Inc. YMAB | Sofinnova Venture Partners X L.P. | 2,271,611 5.200% | 160,222 (+7.59%) | Filing |